Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis.

This study was performed to evaluate the soluble interleukin-4 receptor (sIL-4R) as a potential antagonist of interleukin-4 (IL-4) in an infectious disease. It is shown that antigen-triggered proliferation and cytokine secretion of Leishmania major-specific, cloned Th2 cells in vitro can be inhibite...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Infect Immun
Autors principals: Gessner, A, Schröppel, K, Will, A, Enssle, K H, Lauffer, L, Röllinghoff, M
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 1994
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303084/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7927664/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.62.10.4112-4117.1994
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars